2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Highlights on HER2+ mCRC: Is Promising Trastuzumab Deruxtecan Active in Disease Refractory to Standard Therapies?

137 views
July 16, 2020
Comments 0
Login to view comments. Click here to Login